Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

NCT00117117 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00117117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00117117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2002
Completion date
December 31, 2003
Enrollment
2,423
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia